Cigarette maker Godfrey Phillips India Ltd delivered exceptional fourth quarter results with consolidated net profit surging 86% to ₹521.46 crore in Q4FY26, compared to ₹279.61 crore in the corresponding quarter of the previous fiscal year. According to reports from Business Standard, the company's consolidated total revenue from operations reached ₹3,485.54 crore in Q4FY26, significantly higher than ₹1,887.79 crore recorded in the year-ago period. The robust performance was driven by strong sales across the company's product portfolio.
For the complete financial year 2025-26, Godfrey Phillips India demonstrated consistent growth with consolidated net profit standing at ₹1,526 crore, compared to ₹1,072.31 crore in FY25. As reported by Business Standard, the company's consolidated total revenue from operations for the entire financial year reached ₹9,121 crore, substantially higher than ₹6,767.49 crore in the preceding fiscal year. The company's board of directors has recommended a final dividend of ₹3.3 per equity share for 2025-26.
According to the regulatory filing reported by Business Standard, total expenses in Q4FY26 were higher at ₹2,968.42 crore, compared to ₹1,663.92 crore in the corresponding period of the previous year. The increased operational costs reflect the company's expanded business activities and growth initiatives during the quarter.
In a separate filing reported by Business Standard, Godfrey Phillips India's board has approved the signing of a distribution agreement with Aspeya India Pvt Ltd, a member entity of Philip Morris Global Brands Inc, USA, the foreign promoter shareholder of the company. Under this three-year initial term agreement, GPI will purchase nicotine replacement therapy products from Aspeya and distribute them using its established distribution network through approved trade channels.
